Phase 3 Trial of Actemra for Systemic Sclerosis Completes Enrollment

Author: Genentech
Date Published: August-2017
Source: Healio

This week, Genentech announced its phase 3 trial of Actemra for patients with systemic sclerosis has completed enrollment. The study will compare the drug’s safety and efficacy with placebo in patients with systemic sclerosis, according to a press release.